Prescription Drug Spending for Behavioral Health: Impact of the Medicare Modernization Act

Medstat / University of Maryland
12/01/05 - 04/07/06

Dennis Shea, Department of Health Policy and Administration

This study, sponsored by Thomson Medstat, resulted in a report that examines the clinical, economic and policy factors associated with projected spending for pharmacologic treatments for mental health and substance use disorders.